Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its ability to detect and...

Brigham and Women's Hospital researchers have developed a promising "dual action" treatment for lung cancer that combines immunotherapy with...

Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at...

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...

Scientists at the University of California San Diego, USA, have developed microrobots capable of delivering cancer drugs directly to metastatic lung...

An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in...

Brigham's dual-action treatment shows promise in preclinical lung cancer models, enhancing drug delivery and immune response.

Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...

Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as...